Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...
Jo Varshney, PhD, DVM, discusses how artificial intelligence–powered simulations speed drug approvals and reduce clinical ...
IIT Madras announces the 'PURE' AI framework, promising significant reductions in drug development timelines. Developed with Ohio State University, PURE uses reinforcement learning to optimize ...
If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...
On October 27, Thermo Fisher Scientific and Lundbeck both announced new collaborations with OpenAI. These moves represent a continuing trend of drug development companies inking deals with technology ...
In this week’s edition of InnovationRx, we look Nvidia’s collaborations in life sciences and drug development, Cobot’s ...
The wide range of chromatographic techniques share one common aim: to separate a material into its components. A material, your sample, is dissolved in a solvent, called the mobile phase. This mixture ...
2hon MSN
Trump team is negotiating with weight-loss drug makers to lower prices to $149 a month: report
Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that ...
State-of-the-art AI programs can support the development of drugs by predicting how proteins interact with small molecules.
6don MSN
FDA to streamline approvals for generic biological drugs in latest move targeting health costs
The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...
Data from Catalent’s preclinical studies evaluating certepetide as a SMARTag® ADC payload showed both improved tumor selective penetration and efficacy BASKING RIDGE, N.J., Nov. 04, 2025 (GLOBE ...
George Tidmarsh, the FDA's top drug regulator, has been placed on leave after being accused of abusing his regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results